CampETEC Hyperimmune Bovine Colostrum (HBC)

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

June 4, 2024

Study Completion Date

June 4, 2025

Conditions
Healthy Volunteer
Interventions
BIOLOGICAL

CampETEC HBC product

Immunoglobulin from bovine milk/colostrum and challenge strain

BIOLOGICAL

ProMilk 85

Placebo ProMilk 85

BIOLOGICAL

C. jejuni CG8421 Challenge strain

Challenge strain C. jejuni CG8421

Trial Locations (1)

21224

Johns Hopkins University (Center for Immunization Research), Baltimore

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

collaborator

United States Department of Defense

FED

collaborator

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc

UNKNOWN

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT06122870 - CampETEC Hyperimmune Bovine Colostrum (HBC) | Biotech Hunter | Biotech Hunter